Since compounds 1−5 exhibited cytotoxic effects against FLT3-driven acute myeloid leukemia cells such as MOLM-13 and MV-4-11, they were tested in a cell-free assay to evaluate FLT3 kinase inhibition. Here, FLT3 is linked to acute myeloid leukemia.